Health and Healthcare

BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

77 Articles

Chris Lange | Feb 13, 2016 at 10:15 AM EST

4 BioPharma Movers That Cannot Be Ignored

These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of…

Jon C. Ogg | Feb 8, 2016 at 11:05 AM EST

Is BioCryst Reaching Crush Depth?

BioCryst Pharmaceuticals shares were crushed after it announced results from OPuS-2 for the treatment of hereditary angioedema attacks.

Lee Jackson | Jan 23, 2016 at 10:10 AM EST

Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More

For the third straight week, insider selling has been nonexistent, while the insider buyers have taken advantage of the market…

Lee Jackson | Jan 12, 2016 at 8:35 AM EST

Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start

Jefferies is out with its first group of growth stocks to buy this year, and the list has not only…

Jon C. Ogg | Jan 6, 2016 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels,…

Chris Lange | Nov 28, 2015 at 10:16 AM EST

4 Key FDA Decisions Expected By Year End

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There…

Chris Lange | Nov 1, 2015 at 9:10 AM EST

4 Key FDA Decisions Expected in November and December

24/7 Wall St. has collected several big FDA decisions coming up in the month of November.

Jon C. Ogg | Oct 9, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Friday's top analyst upgrades, downgrades and initiations include AT&T, BioCryst Pharmaceuticals, Eli Lilly, Facebook, Flextronics, Gap and Tesla Motors.

Chris Lange | Apr 20, 2015 at 4:11 PM EDT

BioCryst Upgrade Almost Looks Misunderstood

The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals may be very misunderstood for what it is.

Chris Lange | Apr 18, 2015 at 9:40 AM EDT

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks…

Chris Lange | Mar 31, 2015 at 3:45 PM EDT

Ebola Finances Coming Back in the News

Within the past week, two Ebola-related companies are showing renewed optimism for their positions, whether it is securing a contract…

Jon C. Ogg | Dec 1, 2014 at 2:10 PM EST

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.

Chris Lange | Nov 12, 2014 at 2:10 PM EST

Ebola Stock Short Interest Surprise

Some Ebola-related stocks had been heavily shorted as they were considered by many investors as the next would-be stock bubble…

Jon C. Ogg | Oct 23, 2014 at 3:30 PM EDT

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

ThinkstockJust when you thought the Ebola virus outbreak risk was dwindling down… Fresh headlines from Dow Jones and the New…

Jon C. Ogg | Oct 20, 2014 at 10:45 AM EDT

Ebola Stock Fallout Severe on Monday

Some of the Ebola high-flying stocks saw their share prices crater on Monday as Ebola fears are subsiding for several…

1 2 3 4 5 6

BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

4 BioPharma Movers That Cannot Be Ignored

Is BioCryst Reaching Crush Depth?

Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More

Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

4 Key FDA Decisions Expected By Year End

4 Key FDA Decisions Expected in November and December

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

BioCryst Upgrade Almost Looks Misunderstood

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

Ebola Finances Coming Back in the News

5 Critical Biotech Drug Dates and Events for December

Ebola Stock Short Interest Surprise

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Ebola Stock Fallout Severe on Monday

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

BioCryst Pharmaceuticals : BCRX

All BioCryst Pharmaceuticals Articles

4 BioPharma Movers That Cannot Be Ignored

Is BioCryst Reaching Crush Depth?

Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More

Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

4 Key FDA Decisions Expected By Year End

4 Key FDA Decisions Expected in November and December

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

BioCryst Upgrade Almost Looks Misunderstood

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

Ebola Finances Coming Back in the News

5 Critical Biotech Drug Dates and Events for December

Ebola Stock Short Interest Surprise

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Ebola Stock Fallout Severe on Monday

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.